Clinical Trial

Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4

Study acronym: ICHOR
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by two types of anesthesia: Propofol or Dexmedetomidine. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of Propofol and Dexmedetomidine are in clinical equipoise will be offered to have the anesthesia they will receive during their MRI randomized. * Change in cerebral blood flow (ml blood/100g/min) * Change in cerebral metabolic rate of oxygen (ml O2/100g/min) Researchers will compare Propofol (Group A) to Dexmedetomidine (Group B) to see if compare the hemodynamic response to anesthesia. Participants will be randomized to receive one of two equally safe anesthetics (Propofol or Dexmedetomidine).
Trial Details
NCT Number NCT07103616
Lead Sponsor Children's Hospital Los Angeles
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Anesthesia; Reaction, Anesthesia
Enrollment 130 participants
Start Date 2025-09-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-05